ing to follow-up biopsies. Outcomes measured include changes in clinical management and incidence of false-positive findings defined as biopsy-evaluated PET/CT findings nondiagnostic for melanoma. Fisher exact tests were used to compare clinical factors with PET/CT use.
No takes yet. Share an insight, caveat, or question.
Unger et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: